ClinicalTrials.gg
Active, not recruitingNCT03105518Updated Jul 29, 2026Results posted

Predictors of Postoperative Pain Following Oocyte Retrieval for Assisted Reproduction

A Phase 4 interventional study of Fentanyl and Acetaminophen in Oocyte Retrieval and Postoperative Pain, sponsored by Brigham and Women's Hospital. Active, not recruiting at 1 site in United States. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-29.

Sponsored by Brigham and Women's Hospital · Phase 4, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 3 years 7 months after the study started (first participant enrolled Mar 2011, registered Oct 2014).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
18 Years to 50 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 47 studies testing fentanyl in Pain, Postoperative — 5 open to participants now, 6 under way, none of them phase 3. Fentanyl · Pain, Postoperative.

Enrollment
12th of 47
100 · median 80
Started
2011
with 2 others
Phase 4
22 of 47
2 open now
Registered
18th of 47
by date

Among the 47 studies testing fentanyl in Pain, Postoperative, this one is the 12th largest by enrollment, is one of 3 that started in 2011, is one of 22 in phase 4, and was the 18th registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

5 of the 47 studies testing fentanyl in Pain, Postoperative are open now, in 3 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

About fentanyl

Fentanyl: first FDA approval 1968 (SUBLIMAZE PRESERVATIVE FREE), first EMA approval 2006. What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years to 50 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 47 studies testing fentanyl in Pain, Postoperative, or all of them as a file.
02

Study summary

The central objective of this study will be to evaluate the relationship between estrogen levels and the pain following oocyte retrieval in women undergoing in vitro fertilization.

Read the detailed description

Subject will undergo standard clinical protocols for the entire oocyte stimulation cycle and all assisted reproductive procedure decisions and algorithms will be decided entirely independent of this study.

The anesthetic and postoperative pain regimens will use the same agents and dose ranges used in clinical standard practice; however, the regimens will be standardized, so as to limit confounding variables. The study regimen for anesthesia will differ from the current, clinical standard by the mandated use of actual body weight (in current practice, actual, adjusted ideal, or ideal body weights are used), the use of fentanyl 1 mcg/kg IV (instead of 100 mcg for everyone), and the standardization of postoperative analgesia (noted below). The total amount of fentanyl, propofol, and postoperative drugs will be recorded.

Postoperative analgesia will be standardized based on the subject's self reported verbal analogue score (VAS) and the timing of the report. The agents and timing used below differ from the current clinical standard by assessing VAS and responding with a certain regimen.

03

Conditions studied

  • Oocyte Retrieval
  • Postoperative Pain

Browse trials for

Keywords

  • assisted reproduction
  • postoperative pain
  • opioid
04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • (ASA) I to III health status (moderate systemic disease),
  • Age between 18 and 50 yrs
  • Undergoing oocyte retrieval with intravenous general anesthesia.

Exclusion criteria

Exclusion Criteria:

  • Refuse or withdraw their consent
  • Fail to adequately respond to IVF stimulations medications, and thus are not eligible for oocyte retrieval.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    Analgesia options

    Protocolized analgesia based on VAS degree of discomfort and time. Analgesic options include heating pad, acetaminophen, percocet (oxycodone), fentanyl 0.5-1 mcg/kg.

    Drug: Fentanyl · Drug: Acetaminophen · Drug: Oxycodone

Interventions

  • 0.5, 1 mcg/kg

    Also known as: Sublimaze

  • Single + Oxycodone

    Also known as: Tylenol

  • With Acetaminophen

    Also known as: Percocet

06

What researchers measure

Primary outcomes

  1. Amount of Discomfort

    Change in discomfort following oocyte retrieval with standardized anesthesia management as measured by verbal analogue scoring (0-10 scale). VAS scores correlate to minimal (VAS 0-3), moderate (VAS 4-6) or severe (VAS ≥7) discomfort.

    Time frame: PACU admission, 15, 30 and 60 min postprocedure, postoperative day 3

Secondary outcomes

  1. Amount of Discomfort Following Discharge Until Embryo Transfer

    Change in discomfort following oocyte retrieval with standardized anesthesia management as measured by verbal analogue scoring (0-10 scale) after immediate postoperative period (1 hrs) but prior to Embryo Transfer on 3rd postoperative day. Visual Analogue Scale (VAS) scores correlate to minimal (VAS 0-3), moderate (VAS 4-6) or severe (VAS ≥7) discomfort. Patients will record the type, dose, and timing of pain medicines in a diary to be returned at Embryo Transfer.

    Time frame: After 1 hrs but less than 3 days

07

Results

Posted Dec 5, 2017
Limitations and caveats
No limitations or caveats noted for this study.

Participant flow

Participant flow — Overall Study
MilestoneAnalgesia Options
Started100
Completed100
Not completed0

Outcome measures

PrimaryAmount of Discomfort

Change in discomfort following oocyte retrieval with standardized anesthesia management as measured by verbal analogue scoring (0-10 scale). VAS scores correlate to minimal (VAS 0-3), moderate (VAS 4-6) or severe (VAS ≥7) discomfort.

Time frame:
PACU admission, 15, 30 and 60 min postprocedure, postoperative day 3
Reported as:
Mean · units on a scale
Amount of Discomfort
units on a scaleAnalgesia Options
Time 0; ≤10 Follicles1.53 ± 2.13
Time 0; > 10 Follicles3.25 ± 2.9
Time 15; ≤10 Follicles2.68 ± 2.19
Time 15; >10 Follicles3.61 ± 1.98
Time 30; ≤10 Follicles1.66 ± 1.40
Time 30; >10 Follicles2.93 ± 1.43
Time 60; ≤10 Follicles0.97 ± 1.16
Time 60; >10 Follicles2.19 ± 1.55
Time POD 3; ≤ 10 Follicles1.44 ± 1.15
Time POD 3; > 10 Follicles1.64 ± 1.82
Statistical analysis
  • Analgesia Options · Kruskal-Wallis · p = 0.007 · 1 way test, chisquare approximation: 7.1880
  • Analgesia Options · Kruskal-Wallis · p = 0.056 · 1 way test, chisquare approximation: 3.6396
  • Analgesia Options · Kruskal-Wallis · p = <0.0001 · 1 way test, chisquare approximation: 15.971
  • Analgesia Options · Kruskal-Wallis · p = <0.0001 · 1-way test, chisquare approximation: 16.0972
SecondaryAmount of Discomfort Following Discharge Until Embryo Transfer

Change in discomfort following oocyte retrieval with standardized anesthesia management as measured by verbal analogue scoring (0-10 scale) after immediate postoperative period (1 hrs) but prior to Embryo Transfer on 3rd postoperative day. Visual Analogue Scale (VAS) scores correlate to minimal (VAS 0-3), moderate (VAS 4-6) or severe (VAS ≥7) discomfort. Patients will record the type, dose, and timing of pain medicines in a diary to be returned at Embryo Transfer.

Time frame:
After 1 hrs but less than 3 days
Reported as:
Mean · units on a scale
Amount of Discomfort Following Discharge Until Embryo Transfer
units on a scaleAnalgesia Options
POD1; ≤10 Folli2.15 ± 1.72
POD1; >10 Follicles3.21 ± 1.87
POD2; ≤10 Folli1.28 ± 1.89
POD2; >10 Folli2.50 ± 2.35
Statistical analysis
  • Analgesia Options · Kruskal-Wallis · p = 0.0991 · 1-way test, chisquare approximation: 2.7205
  • Analgesia Options · Kruskal-Wallis · p = 0.2109 · 1 way test, chisquare approximation: 1.5654
  • Analgesia Options · Kruskal-Wallis · p = 0.9287 · 1-way test, chisquare approximation: 0.0080

Adverse events

Collected over 3 days. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Analgesia Options0/100 (0%)0/100 (0%)0/100 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Analgesia Options
Mean35.54 ± 4.61
Sex: Female, Male
Sex: Female, Male(Participants)Analgesia Options
Female100
Male0
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Analgesia Options
Hispanic or Latino5
Not Hispanic or Latino95
Unknown or Not Reported0
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Analgesia Options
American Indian or Alaska Native0
Asian5
Native Hawaiian or Other Pacific Islander0
Black or African American5
White90
More than one race0
Unknown or Not Reported0
08

Study locations

1 site
09

References and documents

Publications

  • Harnett MJ, Bhavani-Shankar K, Datta S, Tsen LC. In vitro fertilization-induced alterations in coagulation and fibrinolysis as measured by thromboelastography. Anesth Analg. 2002 Oct;95(4):1063-6, table of contents. doi: 10.1097/00000539-200210000-00050. PubMed 12351295 ↗
  • Bader AM, Datta S, Moller RA, Covino BG. Acute progesterone treatment has no effect on bupivacaine-induced conduction blockade in the isolated rabbit vagus nerve. Anesth Analg. 1990 Nov;71(5):545-8. doi: 10.1213/00000539-199011000-00016. PubMed 2221417 ↗
  • Datta S, Lambert DH, Gregus J, Gissen AJ, Covino BG. Differential sensitivities of mammalian nerve fibers during pregnancy. Anesth Analg. 1983 Dec;62(12):1070-2. PubMed 6650889 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2011 (actual). Primary completion is estimated for Jun 2027, 195 months after the start.

Of 535 non-industry phase 4 interventional studies under Pain, Postoperative, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 32. This study's planned 195 months is above that.

Counting every sponsor, half of 545 studies reached it within 16 months; a quarter within 8 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 5, 2014
First posted
Apr 10, 2017
StartActual
Mar 1, 2011
Primary completionEst.
Jun 30, 2027
CompletionEst.
Jun 30, 2027
Results first posted
Dec 5, 2017
Last update
Jul 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03105518
Responsible party
Lawrence Ching Tsen (Vice Chair, Faculty Development and Education; Associate Professor, Brigham and Women's Hospital) — Principal investigator
First posted
Apr 10, 2017
Start date
Mar 1, 2011
Primary completion
Jun 30, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Results posted
Dec 5, 2017
Last update
Jul 29, 2026

Study contacts

Lawrence C Tsen, MD
principal investigator · Brigham and Women's Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Fentanyl · Acetaminophen · Oxycodone

Start the discussion